Cargando…
Neutropenia and G-CSF in lymphoproliferative diseases
BACKGROUND: Chemotherapy-induced neutropenia is a major cause of morbidity and mortality. It frequently causes dose reductions or treatment delay, which can be prevented or treated by the administration of granulocyte-colony-stimulating factor (G-CSF). However, a better knowledge of the incidence, d...
Autores principales: | Ria, Roberto, Reale, Antonia, Moschetta, Michele, Dammacco, Franco, Vacca, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Maney Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648783/ https://www.ncbi.nlm.nih.gov/pubmed/23321273 http://dx.doi.org/10.1179/1607845412Y.0000000049 |
Ejemplares similares
-
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies
por: Ria, Roberto, et al.
Publicado: (2014) -
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update
por: Ria, Roberto, et al.
Publicado: (2018) -
Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
por: Reale, Antonia, et al.
Publicado: (2016) -
Managing myelodysplastic symptoms in elderly patients
por: Ria, R, et al.
Publicado: (2009) -
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
por: Berardi, Simona, et al.
Publicado: (2013)